RO is a digital health company that specializes in providing solutions for men's health issues, with a particular focus on treating premature ejaculation. The company offers personalized treatment plans, doctor consultations, and prescribed medication delivered discreetly to patients.

Rob Schutz

Rachel Blank

Saman Rahmanian

Zachariah Reitano

Curology provides personalized skincare treatments delivered to customers' doors. The service involves a consultation and prescription for customized treatments tailored to individual skin concerns.

Curology

CVS Health is a self-described leading health care provider with pharmacy services, and other healthcare related services.

CVS Health

ROC Health Group Ltd is an occupational health company providing private healthcare services. The company delivers comprehensive, tailored occupational health services across various industries.

ROC Health Group Ltd

Workpath

Modern Fertility

Ro is a direct-to-patient healthcare company providing high-quality, affordable healthcare without the need for insurance. Ro is the only company to seamlessly connect telehealth and in-home care, diagnostics, labs, and pharmacy services nationwide. This is enabled by Ro’s vertically integrated platform that powers a personalized, end-to-end healthcare experience from diagnosis, to delivery of medication, to ongoing care. Since 2017, Ro has facilitated more than eight million digital healthcare visits in nearly every county in the United States, including 98% of primary care deserts. Ro also provides its patient-centric solutions including Workpath, its in-home care API, and Kit, its at-home diagnostic testing service, to other healthcare companies.

Our CEO, Zachariah Reitano joined Sara Eisen and Frank Holland on CNBC's Money Movers today to talk about the rapid growth of the GLP-1 market and Ro’s plans for 2024.

Watch the full segment here: https://lnkd.in/eZf9sY3a

#obesitycare #telehealth #chroniccare

You can now stream Big Shot: The Ozempic Revolution on Peacock! 

The documentary showcases the impact of GLP-1s and how Ro is supporting patients with high-quality obesity care via telehealth.

#documentary #glp1s

Hello, New York City! 👋 Have you spotted Ro Sparks while commuting through Penn Station? 

A direct result of patient feedback and insights, Ro Sparks is our newest product to support patients living with erectile dysfunction (ED). Our patients asked for a fast-acting, long-lasting, convenient option that allows them to be spontaneous with their partners. 

Sparks is a sublingual (dissolves under the tongue) treatment that works fast, lasts 36 hours, and is not impacted by food intake.

#sexualhealth #patientcentric #OOH

Our CEO, Zachariah Reitano joined Bob Safian for a new episode of the Masters of Scale Rapid Response podcast.

Zach shared how listening to what our patients want and seeing his own father's experience inspired Ro to build the Body Program. 

Listen to the full episode for a wide-ranging conversation on Ro’s belief in the promise and impact of GLP-1s, our ability to help address weight stigma, and how the Body Program expands access to high-quality obesity care. Listen to the full conversation here: https://lnkd.in/g3FzxjrP

Zachariah Reitano, Ro's CEO, shared with Men's Health some tips and lessons learned from his years leading our team.

Read for his insights on receiving feedback, working hard, and moving quickly: https://lnkd.in/eAZ_gXYF

Metric
Company Name	RO	Curology	CVS Health	ROC Health Group Ltd
Symbol
MSH ID	CO:RO	COM:CUROLOGY	COM:CVSH	COM:ROCHEALTHSERVICES
Market	PRIVATE	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services	Healthcare & Health Services
Industry	Healthcare	Beauty and Personal Care	Healthcare	Healthcare
Country	US	US	US	GB
Stage	Venture Round	Venture Round
Employee Count	884
Website	ro.co	curology.com	cvsh.com	rochealthservices.com
LinkedIn	ro	curology	cvsh
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	4.21M	1.07M
Web Traffic Growth	0.34	-0.04
Valuation
Raised Capital	150M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

CO:RO

RO

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue